zwittergent 3-12 has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; Deng, Y; Gou, J; He, H; Liu, H; Tang, X; Wei, M; Xu, X; Yin, T; Zhang, Y | 1 |
1 other study(ies) available for zwittergent 3-12 and Alloxan Diabetes
| Article | Year |
|---|---|
In situ rearranged multifunctional lipid nanoparticles via synergistic potentiation for oral insulin delivery.
Topics: Administration, Oral; Animals; Caco-2 Cells; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Humans; Insulin; Micelles; Nanoparticles; Rats | 2023 |